DCM Shriram Consolidated , a diversified conglomerate, has reported a robust financial performance for the second quarter, accompanied by a significant dividend announcement and strategic acquisition.

Financial Highlights

The company's consolidated financial results for Q2 showcase substantial growth:

The company's performance shows significant improvement across all key financial metrics. The revenue from operations grew by 9.66% year-over-year, while EBITDA saw a remarkable 73.53% increase. Most notably, the net profit more than doubled, registering a 152.25% jump compared to the same quarter in the previous fiscal year.

Dividend Declaration

The Board of Directors has declared an interim dividend of ₹3.60 per equity share. This dividend, which represents 180% of the face value of ₹2 per share, will be paid to eligible shareholders within 30 days of the declaration.

Segment Performance

The company's diverse business segments contributed to its overall growth:

1. Chemicals and Vinyl: This segment emerged as the top performer, with revenue of ₹1,108.40 crore and a segment profit of ₹200.71 crore.
2. Sugar and Ethanol: This segment reported revenue of ₹1,093.71 crore.
3. Shriram Farm Solutions: The segment showed strong growth with revenue of ₹471.02 crore and a segment profit of ₹104.53 crore.

Strategic Acquisition

DCM Shriram has completed the acquisition of 100% shareholding in Hindusthan Speciality Chemicals Limited as of August 26, 2025. This strategic move is expected to strengthen the company's position in the specialty chemicals sector.

Operational Update

The company has commissioned an Epichlorohydrin (ECH) Plant with a capacity of 35,000 TPA at its chemical complex in Jhagadia, Bharuch District, Gujarat. The remaining 17,000 TPA capacity is expected to be commissioned shortly, further enhancing the company's production capabilities.

Management Commentary

Ajay S. Shriram, Chairman & Senior Managing Director of DCM Shriram Limited, stated, "Our Q2 results reflect the strength of our diversified business model and our ability to capitalize on market opportunities. The significant improvement in our financial metrics, particularly the doubling of our net profit, underscores the effectiveness of our strategic initiatives and operational efficiency."

He added, "The declaration of an interim dividend reaffirms our commitment to delivering value to our shareholders. Furthermore, the acquisition of Hindusthan Speciality Chemicals and the commissioning of our new ECH plant are important steps in our growth strategy, positioning us well for future expansion in the specialty chemicals sector."

DCM Shriram Consolidated , a diversified company with interests in various sectors, has announced a board meeting scheduled for October 28, 2025. The meeting agenda includes the review of unaudited financial results for the second quarter and first half of the fiscal year 2025-26, along with the consideration of an interim dividend.

Key Meeting Details

Dividend Record Date

Should the board approve an interim dividend, the company has set November 3, 2025, as the record date for determining shareholder eligibility. This decision aligns with Regulation 42 of the SEBI Listing Obligations and Disclosure Requirements (LODR).

Trading Window Closure

In compliance with regulatory requirements, DCM Shriram has implemented a trading window closure:

This temporary restriction on trading in the company's equity shares by designated persons is a standard practice to prevent insider trading and ensure fair market practices.

Investor Implications

Shareholders and potential investors should note these key dates:

1. Board Meeting (October 28, 2025): Financial performance review and potential dividend decision.
2. Record Date (November 3, 2025): Determines dividend eligibility, if approved.

Investors are advised to monitor official company communications for the outcome of the board meeting and any subsequent announcements regarding the interim dividend.

DCM Shriram's disclosure of these dates demonstrates its commitment to transparent corporate governance and timely communication with stakeholders. Investors are encouraged to conduct their own research and consider their financial goals before making investment decisions based on this information.